menu
    • menu

    Company profile for Galderma

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Galderma, the world's largest independent global dermatology company, was created in 1981 and is now present in over 100 countries with an extensive product portfolio of prescription medicines, aesthetics solutions and consumer care products. The company partners with health care practitioners around the world to meet the skin health needs of people throughout their lifetime. Galderma is a leader in research and development of...
    Galderma, the world's largest independent global dermatology company, was created in 1981 and is now present in over 100 countries with an extensive product portfolio of prescription medicines, aesthetics solutions and consumer care products. The company partners with health care practitioners around the world to meet the skin health needs of people throughout their lifetime. Galderma is a leader in research and development of scientifically-defined and medically-proven solutions for the skin.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    GaldermaSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    World Trade Center, Avenue Gratta-Paille 2, 1018 Lausanne
    Telephone
    Telephone
    +41 21 642 78 00
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.galderma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/galderma-/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/galderma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Galderma Initiates Study On Nemolizumab For Chronic Pruritus
    Galderma Initiates Study On Nemolizumab For Chronic Pruritus

    11 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-11/galderma-announces-first-patient-enrollment-in-study-to-assess-nemolizumab-in-adults-with-chronic-pr

    PHARMIWEB
    11 Dec 2025
    Share Share
    Galderma Welcomes Increased Equity Investment From L’Oréal
    Galderma Welcomes Increased Equity Investment From L’Oréal

    08 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251207921992/en/Galderma-Welcomes-Increased-Equity-Investment-From-LOral

    BUSINESSWIRE
    08 Dec 2025
    Share Share
    Galderma Showcases Innovative Aesthetic Injectables Portfolio
    Galderma Showcases Innovative Aesthetic Injectables Portfolio

    17 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251116115085/en/ASDS-2025-Compelling-New-Data-on-Restylane-Sculptra-and-Relfydess-Highlight-Galdermas-Innovative-Injectable-Aesthetics-Portfolio-and-Pipeline

    BUSINESSWIRE
    17 Nov 2025
    Share Share
    Galderma Completes Successful Placement Of CHF 175 Million Bond
    Galderma Completes Successful Placement Of CHF 175 Million Bond

    14 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251113705213/en/Galderma-Completes-Successful-Placement-of-CHF-175-Million-Bond

    BUSINESSWIRE
    14 Nov 2025
    Share Share
    Galderma Plans To Spend $650M On Us-Based Manufacturing
    Galderma Plans To Spend $650M On Us-Based Manufacturing

    23 Oct 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/manufacturing/sales-nemluvio-booming-galderma-pledges-spend-650m-us-manufacturing

    FIERCE PHARMA
    23 Oct 2025
    Share Share
    Galderma Achieves $3.737B In 9-Month Net Sales, Up 15% YoY
    Galderma Achieves $3.737B In 9-Month Net Sales, Up 15% YoY

    23 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251022731015/en/Galderma-Delivers-Record-Net-Sales-of-3.737-Billion-USD-in-the-First-Nine-Months-of-2025-and-15.0-Year-on-Year-Growth-at-Constant-Currency-Raises-Full-Year-Guidance

    BUSINESSWIRE
    23 Oct 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search